House mark for pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, protein-energy wasting, and multiple sclerosis; pharmaceutical and therapeutic preparations for the treatment of autoimmune diseases and disorders; none of the foregoing to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis

'age':22 'arthriti':58 'autoimmun':40 'cachexia':21 'cancer':17 'chronic':14 'diabet':20 'diseas':15,19,41 'disord':43 'energi':27 'forego':47 'hous':1 'kidney':18 'mark':2 'multipl':30 'name':16 'none':44 'patient':12 'pharmaceut':4,32,52 'prepar':7,35,53 'protein':26 'protein-energi':25 'psoriasi':60 'relat':23 'rheumatoid':57 'sarcopenia':24 'sclerosi':31 'therapeut':6,34 'treatment':10,38,55 'use':50 'wast':28

ATARA

Owners

Goods & Services